Influence of ablative margiInfluence margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation

Acta Radiologica

Volumn 53, Issue 4, 2012, Pages 394-400

  Francica, Giampiero ^a   Petrolati, Alesssandra ^b   Di Stasio, Enrico ^c   Pacella, Sara ^b   Stasi, Roberto ^d   Pacella, Claudio Maurizio ^b  

^a S Maria della Pietà Hospital   (Italy)

^b REGINA APOSTOLORUM HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Laser; Liver; Thermal ablation

Indexed keywords

CIRRHOSIS; HEPATOCELLULAR CARCINOMA; KAPLAN-MEIER METHOD; MEAN PERIOD; SURVIVAL CURVES; SURVIVAL PROBABILITIES; SURVIVAL TIME; THERMAL ABLATION; TUMOR PROGRESSIONS;

ABLATION; LASER ABLATION; LASERS; LIVER; TUMORS;

PATIENT TREATMENT;

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; DISEASE COURSE; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PROBABILITY; RETROSPECTIVE STUDY; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HUMANS; LASER THERAPY; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROBABILITY; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84860622670     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2012.110471     Document Type: Article

References (35)

1. Forner A, Bruix J. Ablation for hepatocellular carcinoma: Is there need to have a winning technique? J Hepatol 2010;52:310-2
2. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8
3. Ebara M, Okabe S, Kita K, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005;43:458-64 (Pubitemid 41111427)
4. Livraghi T. Radiofreqeuncy ablation of hepatocellular carcinoma. Surg Oncol Clin N Am 2011;20:281-99
5. Liang P, Wang Y, Yu X, et al. Malignant liver tumors: treatment with percutaneous microwave ablation-complications among cohort of 1136 patients. Radiology 2009;251:933-40
6. Pacella CM, Bizzarri G, Magnolfi F, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology 2001;221:712-20 (Pubitemid 33101763)
7. McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. Am J Roentgenol 2001;176:3-16
8. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007;17:684-92
9. Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005;242:158-71 (Pubitemid 41033431)
10. Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003;38:977-81 (Pubitemid 37455785)
11. Kim SH, Lim HK, Choi D, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. Am J Roentgenol 2006;186:327-33
12. Kim YS, Rhim H, Cho OK, et al. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 2006;59:432-41 (Pubitemid 44301741)
13. Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003;97:1253-62 (Pubitemid 36237312)
14. Kei SK, Rhim H, Choi D, et al. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. Am J Roentgenol 2008;190:1544-51 (Pubitemid 351798530)
15. Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. Am J Roentgenol 2007;188:480-8 (Pubitemid 46170753)
16. Liu CH, Arellano RS, Uppot RN, et al. Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol 2010;20:877-85
17. Peng ZW, Zhang YJ, Chen MS, et al. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol 2008;17:23-31
18. Okusaka T, Okada S, Ueno H, et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer 2002;95:1931-7 (Pubitemid 35222173)
19. Sasaki A, Kai S, Iwashita Y, et al. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 2005;103:299-306 (Pubitemid 40129289)
20. Kim YS, Lee WJ, Rhim H, et al. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (. 2 and, 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. Am J Roentgenol 2010;195:758-65
21. Pacella CM, Bizzarri G, Francica G, et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol 2005;16:1447-57 (Pubitemid 43017688)
22. Francica G, Iodice G, Delle Cave M, et al. Factors predicting complete necrosis rate after ultrasound-guided percutaneous laser thermoablation of small hepatocellular carcinoma tumors in cirrhotic patients: a multivariate analysis. Acta Radiol 2007;48:514-9 (Pubitemid 46801823)
23. Arienti V, Pretolani S, Pacella CM, et al. Complications of laser ablation for hepatocellular carcinoma: a multicenter study. Radiology 2008;246:947-55
24. Pacella CM, Francica G, Di Lascio FM, et al. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis. J Clin Oncol 2009;27:2615-21
25. Pacella CM, Bizzarri G, Francica G, et al. Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablation. J Hepatol 2006;44:902-9
26. Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006;43:1101-8 (Pubitemid 43724634)
27. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005;235:728-39 (Pubitemid 40695866)
28. Kim SK, Lim HK, Kim YH, et al. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics 2003;23:107-21 (Pubitemid 37421439)
29. Chau GY, Lui WY, Tsay SH, et al. Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients. J Surg Oncol 1997;66:122-6
30. Poon RT, Fan ST, Ng IO, et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg 2000;231:544-51 (Pubitemid 30185862)
31. Shi M, Guo RP, Lin XJ, et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 2007;245:36-43 (Pubitemid 46035433)
32. Matsui Y, Terakawa N, Satoi S, et al. Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection. Arch Surg 2007;142:596-602 (Pubitemid 47080436)
33. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular Carcinoma: radiofreqeuncy ablation of medium and large lesions. Radiology 2000;214:761-8 (Pubitemid 30115377)
34. Ng KK, Poon RT, Lo CM, et al. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 2008;12:183-91
35. Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-60 (Pubitemid 39657009)